We found that HNRNPK was highly expressed in cancer patients of lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) (Fig. 3c, p-values < 0.001 for Wilcoxon’s rank sum test). Here, HNRNPK is linked to cancer.